150 related articles for article (PubMed ID: 18171518)
21. Evaluation of liver biopsy in Egyptian HBeAg-negative chronic hepatitis B patients at initial presentation: implications for therapy.
El-Zayadi AR; Badran HM; Saied A; Shawky S; Attia Mel-D; Zalata K
Am J Gastroenterol; 2009 Apr; 104(4):906-11. PubMed ID: 19293791
[TBL] [Abstract][Full Text] [Related]
22. [Relation of serological markers of hepatitis B virus and alanine transaminase to hepatic tissue pathology in patients with chronic hepatitis B].
Yang XY; Wen FY; Wu JL; Zhou HJ
Nan Fang Yi Ke Da Xue Xue Bao; 2006 Jun; 26(6):892-3. PubMed ID: 16793626
[TBL] [Abstract][Full Text] [Related]
23. Circulating IL-2, IL-10 and TNF-alpha in chronic hepatitis B: their relations to HBeAg status and the activity of liver disease.
Bozkaya H; Bozdayi M; Türkyilmaz R; Sarioglu M; Cetinkaya H; Cinar K; Köse K; Yurdaydin C; Uzunalimoglu O
Hepatogastroenterology; 2000; 47(36):1675-9. PubMed ID: 11149030
[TBL] [Abstract][Full Text] [Related]
24. [Relationship among pathological changes in Liver tissues and level of serum HBV DNA, HBeAg and ALT of 194 patients with chronic hepatitis B].
Zhao DY; Qin YQ; Tang XM; Liu GZ; Zheng W; Nong HR; Song JJ; Xie QY
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2007 Mar; 21(1):35-7. PubMed ID: 17429530
[TBL] [Abstract][Full Text] [Related]
25. Significance of HBV DNA levels in liver histology of HBeAg and Anti-HBe positive patients with chronic hepatitis B.
Yuen MF; Ng IO; Fan ST; Yuan HJ; Wong DK; Yuen JC; Sum SS; Chan AO; Lai CL
Am J Gastroenterol; 2004 Oct; 99(10):2032-7. PubMed ID: 15447768
[TBL] [Abstract][Full Text] [Related]
26. Significant changes in liver stiffness measurements in patients with chronic hepatitis B: 3-year follow-up study.
Fung J; Lai CL; Wong DK; Seto WK; Hung I; Yuen MF
J Viral Hepat; 2011 Jul; 18(7):e200-5. PubMed ID: 21692933
[TBL] [Abstract][Full Text] [Related]
27. Significant prevalence of histologic disease in patients with chronic hepatitis B and mildly elevated serum alanine aminotransferase levels.
Tsang PS; Trinh H; Garcia RT; Phan JT; Ha NB; Nguyen H; Nguyen K; Keeffe EB; Nguyen MH
Clin Gastroenterol Hepatol; 2008 May; 6(5):569-74. PubMed ID: 18455697
[TBL] [Abstract][Full Text] [Related]
28. [Association of liver histopathology and clinical features among patients with chronic hepatitis B virus infection].
Lu CT; Gao GS
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2011 Jun; 25(3):214-6. PubMed ID: 21977596
[TBL] [Abstract][Full Text] [Related]
29. Combination of baseline parameters and on-treatment hepatitis B virus DNA levels to start and continue patients with lamivudine therapy.
Yuen MF; Fung J; Seto WK; Wong DK; Yuen JC; Lai CL
Antivir Ther; 2009; 14(5):679-85. PubMed ID: 19704171
[TBL] [Abstract][Full Text] [Related]
30. Pretherapy alanine transaminase level as a determinant for hepatitis B e antigen seroconversion during lamivudine therapy in patients with chronic hepatitis B. Asian Hepatitis Lamivudine Trial Group.
Chien RN; Liaw YF; Atkins M
Hepatology; 1999 Sep; 30(3):770-4. PubMed ID: 10462384
[TBL] [Abstract][Full Text] [Related]
31. Extended lamivudine treatment in patients with chronic hepatitis B enhances hepatitis B e antigen seroconversion rates: results after 3 years of therapy.
Leung NW; Lai CL; Chang TT; Guan R; Lee CM; Ng KY; Lim SG; Wu PC; Dent JC; Edmundson S; Condreay LD; Chien RN;
Hepatology; 2001 Jun; 33(6):1527-32. PubMed ID: 11391543
[TBL] [Abstract][Full Text] [Related]
32. High prevalence of significant liver fibrosis and cirrhosis in chronic hepatitis B patients with normal ALT in central Europe.
Göbel T; Erhardt A; Herwig M; Poremba C; Baldus SE; Sagir A; Heinzel-Pleines U; Häussinger D
J Med Virol; 2011 Jun; 83(6):968-73. PubMed ID: 21503908
[TBL] [Abstract][Full Text] [Related]
33. Predictive factors for early HBeAg seroconversion in acute exacerbation of patients with HBeAg-positive chronic hepatitis B.
Kim HS; Kim HJ; Shin WG; Kim KH; Lee JH; Kim HY; Jang MK
Gastroenterology; 2009 Feb; 136(2):505-12. PubMed ID: 19101558
[TBL] [Abstract][Full Text] [Related]
34. [Liver histological changes in chronic hepatitis B patients with elevated ALT less than 2 x ULN].
Xian JC; Xu HT; He YL; Shen ML; Chen YB; Zhang LX; Xiao L; Li Y; Han LB; Li H; Lu LG
Zhonghua Gan Zang Bing Za Zhi; 2011 Jun; 19(6):431-5. PubMed ID: 22053373
[TBL] [Abstract][Full Text] [Related]
35. [Research of hepatic pathology and clinical characteristics of patients chronic infected with hepatitis B virus in immune tolerant stage].
You SL; Xing HQ; Liu HL; Rong YH; Zhu B; Xin SJ
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2007 Dec; 21(4):374-6. PubMed ID: 18322608
[TBL] [Abstract][Full Text] [Related]
36. Long-term outcome of hepatitis B e antigen-negative hepatitis B surface antigen carriers in relation to changes of alanine aminotransferase levels over time.
Tai DI; Lin SM; Sheen IS; Chu CM; Lin DY; Liaw YF
Hepatology; 2009 Jun; 49(6):1859-67. PubMed ID: 19378345
[TBL] [Abstract][Full Text] [Related]
37. Natural history of chronic HBV infection: a cohort study with up to 12 years follow-up in North Greece (part of the Interreg I-II/EC-project).
Zacharakis GH; Koskinas J; Kotsiou S; Papoutselis M; Tzara F; Vafeiadis N; Archimandritis AJ; Papoutselis K
J Med Virol; 2005 Oct; 77(2):173-9. PubMed ID: 16121378
[TBL] [Abstract][Full Text] [Related]
38. Age as a predictor of significant fibrosis features in HBeAg-negative chronic hepatitis B virus infection with persistently normal alanine aminotransferase.
Tan Y; Ye Y; Zhou X; Chen L; Wen D
PLoS One; 2015; 10(4):e0123452. PubMed ID: 25885705
[TBL] [Abstract][Full Text] [Related]
39. [Liver pathological changes and clinical features of patients with chronic hepatitis B virus infection in their immune tolerant phase and non-active status].
Li J; Zhao GM; Zhu LM; Li Y; Xin SJ
Zhonghua Gan Zang Bing Za Zhi; 2007 May; 15(5):326-9. PubMed ID: 17524261
[TBL] [Abstract][Full Text] [Related]
40. Characterization of viral kinetics in patients with hepatitis B e antigen-positive chronic hepatitis B.
Wu IC; Chow NH; Cheng PN; Liu WC; Young KC; Chang WL; Chen CY; Tseng KC; Chang TT
J Med Virol; 2007 Jun; 79(6):663-9. PubMed ID: 17457902
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
